Featured Videos |view more
Video
Awake Craniotomy and Tumor Resection
Abhay Varma, M.D., MUSC Health neurosurgeon at the Hollings Cancer Center, discusses the awake craniotomy and tumor resection procedure.
Video
Gamma Knife Surgery for Brain Tumors
Gamma Knife Radiosurgery is a service offered by MUSC for treatment of brain tumors, pain syndromes, arteriovenous malformations, epilepsy, and psychiatric disorders.
Video
Robotic Abdominoperineal Resection With Robotic Flap Harvest for Vaginal Reconstruction
Although technically challenging, robotic abdominoperineal resection (APR) with robotic harvest of the rectus abdominus muscular flap can eliminate the need for a midline laparotomy, reduce wound infection rates and lead to faster recovery.
Video
Tumor-Treating Fields for Glioblastoma and Other Brain Tumors
In this video, two MUSC Hollings Cancer Center neuro-oncologists, Scott M. Lindhorst, M.D., and David M. Cachia, M.D., discuss their experience with TTFields and the clinical trials they are leading in patients who have failed Avastin therapy.
Video
New Rule-Out Test for Lung Cancer Increases Diagnostic Precision
Gerard A. Silvestri, M.D., a lung cancer pulmonologist at MUSC, led a study that shows that a new biomarker is 98 percent effective at distinguishing benign from malignant lung nodules.
Video
Reanimating the Paralyzed Face
Samuel L. Oyer, M.D., discusses a technique used in facial reanimation surgery — masseter-to-facial nerve transfer — that can restore a patient’s ability to smile.
Video
Pancreatic Head Resection for Localized Pancreatic Cancer
MUSC Health gastrointestinal surgeon Katherine A. Morgan, M.D., discusses the Whipple procedure as a surgical treatment for localized pancreatic cancer.
Video
Instagrams of the Immune System - Predict Responses to Immunotherapy
Carsten Krieg, Ph.D.,discusses how “Instagrams of the immune system,” captured by a new technology, made it possible to identify biomarkers of response to immunotherapy in patients with melanoma.
Video
Advanced Glycation End Products: A Lifestyle Biomarker
Study of advanced glycation end produces (AGEs) through dietary and exercise intervention to see if improvement of quality of life decreases tumor recurrence in patients.
Featured Documents |view more
Document
Precision Medicine: Exome Sequencing Helps Physicians Target Genomic Variations within Tumors
As part of MUSC's growing transnational genomics program, a genomics tumor board has been created to bring diverse specialists together to help physicians diagnose and manage cancer.
Document
Up From Below: New Minimally Invasive Surgery for Patients with Tumors in the Lower Rectum
Transanal total mesorectal excision (TaTME) has garnered a great surgery because it represents a reversal of perspective—literally— about how best to excise tumors and the surrounding mesorectal envelope in the lower third of the rectum.
Document
A Class ACT: MUSC Immunologists are Optimizng Adoptive Cell Transfer for Antitumor Treatments
Researchers are using adoptive cell transfer (ACT) to reinforce the ranks of a patient’s own T cells—the body’s warriors—and train them to better target the patient’s cancer.
Document
Taking Center Stage: Immunotherapy Joins the Ranks of Mainstream Cancer Treatments
News that novel T cell–based immunotherapeutic approaches such as immune checkpoint blockade and adoptive cell transfer are achieving durable responses in patients with aggressive cancers has created excitement in the world of cancer research.
Document
Genomics screening can improve the odds for some cancer patients, potentially identifying mutations associated with cancer subtypes for which targeted therapies exist or are in development.
The Hollings Cancer Center at the Medical University of South Carolina is a National Cancer Institute-designated cancer center and the largest academic-based cancer research program in South Carolina. The cancer center comprises more than 120 faculty cancer scientists with an annual research funding portfolio of $44 million and a dedication to reducing the cancer burden in South Carolina. Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques within multidisciplinary clinics that include surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and other specialists equipped for the full range of cancer care, including more than 200 clinical trials.
